Cyrus
@mxjagger.bsky.social
📤 84
đź“Ą 105
đź“ť 95
Collage artist, illustrator, they/them www.cyrusfinegan.com
Monoprint No. 33 2026.06.24
5 days ago
0
3
2
Monoprint No. 32 2026.06.24
5 days ago
0
13
3
Monoprint No. 31 2026.06.24
5 days ago
0
0
0
Monoprint No. 30 2026.06.24
5 days ago
0
6
1
Monoprint No. 29 2026.06.24
5 days ago
0
10
1
reposted by
Cyrus
The Cancer Letter
6 days ago
Trump’s text exchange with Rogan notwithstanding, psychedelic medicines haven’t received FDA approvals—at least not yet.
https://cancerletter.com/regulatory-news/20260618_1/
loading . . .
Is psilocybin heading to a cancer clinic near you? Reversing Nixon-era taboo, Trump orders FDA to fast-track psychedelics and ARPA-H to fund research - The Cancer Letter
Earlier this year, Joe Rogan, host of “The Joe Rogan Experience” podcast, sent a text to President Donald Trump. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login Subscribe
https://cancerletter.com/regulatory-news/20260618_1/
0
1
1
Monoprint No. 28 2026.06.22
7 days ago
0
0
0
Monoprint No. 27 2026.06.22
7 days ago
0
1
0
Monoprint No. 26 2026.06.22
7 days ago
0
1
0
Monoprint No. 25 2026.06.22
7 days ago
0
4
1
Monoprint No. 24 2026.06.22
7 days ago
0
1
0
Monoprint No. 23 226.06.22
7 days ago
0
2
1
Monoprint No. 22 2026.06.22
7 days ago
0
1
0
Monoprint No. 21 2026.06.22
7 days ago
0
0
0
Monoprint No. 20 2026.06.22
7 days ago
0
2
1
Monoprint No. 19 2026.06.19
10 days ago
1
1
0
Monoprint No. 18 2026.06.19
10 days ago
0
2
0
I had so much fun playing around with open lid scans and manual glitch effects for this! Always love working with the team at
@cancerletter.com
10 days ago
0
1
0
reposted by
Cyrus
The Cancer Letter
22 days ago
Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
https://cancerletter.com/clinical/20260605_1/
loading . . .
Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival - The Cancer Letter
A note for historians: On April 21, 2026, pancreatic cancer finally began to budge. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login Subscribe
https://cancerletter.com/clinical/20260605_1/
0
2
2
Monoprint No. 17 2026.05.20
about 1 month ago
0
1
0
Monoprint No. 16 2026.05.20
about 1 month ago
0
6
3
Monoprint No. 15 2026.05.20
about 1 month ago
0
8
2
Grief Poem No. 16 2026.05.20
about 1 month ago
0
3
1
Grief Poem No. 15 2026.05.20
about 1 month ago
0
4
1
Monoprint No. 14 2026.05.04
about 2 months ago
0
11
4
Monoprint No. 13 2026.05.04
about 2 months ago
0
7
2
Monoprint No. 12 2026.05.04
about 2 months ago
0
2
0
Monoprint No. 11 2026.05.04
about 2 months ago
0
3
1
Monoprint No. 10 2026.05.04
about 2 months ago
0
9
1
Monoprint No. 9 2026.04.25
2 months ago
0
14
3
Monoprint No. 8 2025.04.26
2 months ago
0
4
2
Monoprint No. 7 2026.04.25
2 months ago
0
1
1
Monoprint No. 6 2026.04.25
2 months ago
0
6
2
Monoprint No. 5 2026.04.25
2 months ago
0
4
1
Monoprint No. 4 2026.04.25
2 months ago
0
5
1
Monoprint No. 3 2026.04.22
2 months ago
0
13
3
Monoprint No. 2 2026.04.22
2 months ago
0
10
3
Monoprint No. 1 2026.04.22
2 months ago
0
3
0
Grief Poem No. 14 2026.04.21
2 months ago
0
1
0
Grief Poem No. 13 2026.04.21
2 months ago
0
0
0
Grief Poem No. 12 2026.03.04
4 months ago
0
6
1
Grief Poem No. 11 2026.02.08
5 months ago
0
8
2
Grief Poem No. 10 2026.02.08
5 months ago
0
6
3
reposted by
Cyrus
The Cancer Letter
5 months ago
For the first time in over 30 years, FDA has approved a “true generic version” of Premarin. “It took a very long time to approve a generic [for Premarin] because it’s so complicated,” said Janet Woodcock, who served as CDER director for over 20 years.
https://cancerletter.com/clinical/20260123_1/
loading . . .
Premarin’s 84-year hold on the market ends as FDA approves a generic version Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer...
A story is told that after first obtaining approval for marketing Premarin in 1942, Wyeth Laboratories didn’t lock up the secret recipe for making the hormonal drug in a company safe, to be guarded by patent lawyers. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in […]
https://cancerletter.com/clinical/20260123_1/
0
1
1
Grief Poem No. 9 2026.01.27
5 months ago
0
3
0
reposted by
Cyrus
The Cancer Letter
5 months ago
Premarin’s 84-year hold on the market ends as FDA approves a generic version Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer
https://cancerletter.com/clinical/20260123_1/
loading . . .
Premarin’s 84-year hold on the market ends as FDA approves a generic version Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer...
A story is told that after first obtaining approval for marketing Premarin in 1942, Wyeth Laboratories didn’t lock up the secret recipe for making the hormonal drug in a company safe, to be guarded by patent lawyers. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in […]
https://cancerletter.com/clinical/20260123_1/
0
1
1
Loooooovved working on this piece for
@cancerletter.com
!!
5 months ago
0
4
0
Grief Poem No. 8 2026.01.13
6 months ago
0
11
3
Grief Poem No. 7 2026.01.13
6 months ago
0
3
2
Grief Poem No. 6 2025.12.18
6 months ago
0
3
0
Load more
feeds!
log in
